{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:18:23Z","timestamp":1772572703133,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1280-3","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T23:04:44Z","timestamp":1428707084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Wei","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiliang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhai","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binkui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"1280_CR1","unstructured":"IARC. Available from: http:\/\/www-dep.iarc.fr: [accessed November 1st, 2011]."},{"key":"1280_CR2","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","volume":"111","author":"J Bruix","year":"1996","unstructured":"Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018\u201322.","journal-title":"Gastroenterology"},{"key":"1280_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/hep.510300629","volume":"30","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434\u201340.","journal-title":"Hepatology"},{"key":"1280_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","volume":"250","author":"A Cucchetti","year":"2009","unstructured":"Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009;250:922\u20138.","journal-title":"Ann Surg"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/01.sla.0000254368.65878.da","volume":"245","author":"M Minagawa","year":"2007","unstructured":"Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC\/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909\u201322.","journal-title":"Ann Surg"},{"key":"1280_CR6","first-page":"553","volume":"12","author":"M An","year":"2006","unstructured":"An M, Park JW, Shin JA, Choi JI, Kim TH, Kim SH, et al. [The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma]. Korean J Hepatol. 2006;12:553\u201361.","journal-title":"Korean J Hepatol"},{"key":"1280_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1478-3231.2010.02436.x","volume":"31","author":"GH Choi","year":"2011","unstructured":"Choi GH, Park JY, Hwang HK, Kim DH, Kang CM, Choi JS, et al. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int. 2011;31:485\u201393.","journal-title":"Liver Int"},{"key":"1280_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00268-005-0524-9","volume":"30","author":"L Capussotti","year":"2006","unstructured":"Capussotti L, Ferrero A, Vigano L, Muratore A, Polastri R, Bouzari H. Portal hypertension: contraindication to liver surgery? World J Surg. 2006;30:992\u20139.","journal-title":"World J Surg"},{"key":"1280_CR9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1245\/s10434-008-9880-7","volume":"15","author":"Y Kawano","year":"2008","unstructured":"Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol. 2008;15:1670\u20136.","journal-title":"Ann Surg Oncol"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","volume":"134","author":"T Ishizawa","year":"2008","unstructured":"Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908\u201316.","journal-title":"Gastroenterology"},{"key":"1280_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1477-2574.2012.00594.x","volume":"15","author":"R Santambrogio","year":"2013","unstructured":"Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford). 2013;15:78\u201384.","journal-title":"HPB (Oxford)"},{"key":"1280_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The L, European Organisation For R, Treatment Of C","year":"2012","unstructured":"European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"1280_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","volume":"7","author":"AA Qamar","year":"2009","unstructured":"Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1280_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1572-0241.2008.01826.x","volume":"103","author":"A Berzigotti","year":"2008","unstructured":"Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol. 2008;103:1159\u201367.","journal-title":"Am J Gastroenterol"},{"key":"1280_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329\u201338.","journal-title":"Semin Liver Dis"},{"key":"1280_CR16","first-page":"554","volume":"91","author":"Y Bayraktar","year":"1996","unstructured":"Bayraktar Y, Balkanci F, Uzunalimoglu B, Gokoz A, Koseoglu T, Batman F, et al. Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy? Am J Gastroenterol. 1996;91:554\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1280_CR17","first-page":"295","volume":"19","author":"L Pagliaro","year":"1987","unstructured":"Pagliaro L, Spina L. The italian programme on liver cirrhosis. Ital J Gastroenterol. 1987;19:295\u20137.","journal-title":"Ital J Gastroenterol"},{"key":"1280_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1471-2407-10-535","volume":"10","author":"B Li","year":"2010","unstructured":"Li B, Yuan Y, Chen G, He L, Zhang Y, Li J, et al. Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? BMC Cancer. 2010;10:535.","journal-title":"BMC Cancer"},{"key":"1280_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1280_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","volume":"242","author":"S Balzan","year":"2005","unstructured":"Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The \"50-50 criteria\" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824\u20138. discussion 828\u2013829.","journal-title":"Ann Surg"},{"key":"1280_CR21","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/sim.3245","volume":"27","author":"J Hill","year":"2008","unstructured":"Hill J. Discussion of research using propensity-score matching: comments on 'A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003' by Peter Austin, Statistics in Medicine. Stat Med. 2008;27:2055\u201361. discussion 2066\u20132059.","journal-title":"Stat Med"},{"key":"1280_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1\u201321.","journal-title":"Stat Sci"},{"key":"1280_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"1280_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421\u201330.","journal-title":"J Hepatol"},{"key":"1280_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/bjs.8753","volume":"99","author":"E Boleslawski","year":"2012","unstructured":"Boleslawski E, Petrovai G, Truant S, Dharancy S, Duhamel A, Salleron J, et al. Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis. Br J Surg. 2012;99:855\u201363.","journal-title":"Br J Surg"},{"key":"1280_CR26","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/bjs.7672","volume":"98","author":"S Stremitzer","year":"2011","unstructured":"Stremitzer S, Tamandl D, Kaczirek K, Maresch J, Abbasov B, Payer BA, et al. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg. 2011;98:1752\u20138.","journal-title":"Br J Surg"},{"key":"1280_CR27","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.3748\/wjg.v17.i46.5083","volume":"17","author":"A Ruzzenente","year":"2011","unstructured":"Ruzzenente A, Valdegamberi A, Campagnaro T, Conci S, Pachera S, Iacono C, et al. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol. 2011;17:5083\u20138.","journal-title":"World J Gastroenterol"},{"key":"1280_CR28","doi-asserted-by":"publisher","first-page":"e64261","DOI":"10.1371\/journal.pone.0064261","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One. 2013;8:e64261.","journal-title":"PLoS One"},{"key":"1280_CR29","doi-asserted-by":"crossref","unstructured":"Romano F, Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, Nespoli A, Uggeri F: Bleeding in Hepatic Surgery: Sorting through Methods to Prevent It. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 2012, 2012:169351.","DOI":"10.1155\/2012\/169351"},{"key":"1280_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00000658-200210000-00001","volume":"236","author":"WR Jarnagin","year":"2002","unstructured":"Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397\u2013406. discussion 406\u2013397.","journal-title":"Ann Surg"},{"key":"1280_CR31","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/liv.12105","volume":"33","author":"EG Giannini","year":"2013","unstructured":"Giannini EG, Savarino V, Farinati F, Ciccarese F, Rapaccini G, Marco MD, et al. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int. 2013;33:1594\u2013600.","journal-title":"Liver Int"},{"key":"1280_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"1280_CR33","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907\u201317.","journal-title":"Lancet"},{"key":"1280_CR34","first-page":"41","volume":"49","author":"J Belghiti","year":"2002","unstructured":"Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology. 2002;49:41\u20136.","journal-title":"Hepatogastroenterology"},{"key":"1280_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00268-010-0928-z","volume":"35","author":"WY Kao","year":"2011","unstructured":"Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg. 2011;35:858\u201367.","journal-title":"World J Surg"},{"key":"1280_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00000658-199901000-00011","volume":"229","author":"N Nagasue","year":"1999","unstructured":"Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surgery. 1999;229:84\u201390.","journal-title":"Ann Surgery"},{"key":"1280_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20871","volume":"42","author":"C Ripoll","year":"2005","unstructured":"Ripoll C, Banares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005;42:793\u2013801.","journal-title":"Hepatology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1280-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1280-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:10:16Z","timestamp":1630581016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1280-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1280-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]},"assertion":[{"value":"5 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"263"}}